Otsuka to spotlight digital therapies for depression at WMIF25
Otsuka Pharmaceutical will lead one of the key expert panels at the WeMind International Forum 2025, bringing together top voices in psychiatry and health policy to examine the future of digital therapies in the treatment of depression.







